Enzalutamide Is Good For Older Patients With Metastatic Castration-Resistant Prostate Cancer
Once a clinical trial has been completed, especially when the trial is positive, researchers will “data mine” the published information. The published results provide additional opportunities to evaluate the data in different ways than the [...]
Not All Men Benefit From Radium-223 (Xofigo)?
Researchers are now beginning to understand which men with castration-resistant prostate cancer (CRPC) might be helped by radium-223 (Xofigo), and for which men Xofigo will be a waste of time and money, and possibly cause harm. They have [...]
Why A Diet Heavy in Fruits and Vegetables Might Help Men With Prostate Cancer
Many people consider food diet important in both prostate cancer prevention and in controlling its progression. Dietary derived agents, such as the flavonoids derived from fruits and vegetables should be of particular interest for prostate [...]
Payment for PSA Prostate Cancer Screening may end
Believe it or not, in this week approaching Thanksgiving, we in the United States are faced with a second challenge to Prostate Cancer screening using the PSA test. Malecare wants you to know. The [...]
Malecare Issued Patent For A Device and Method Which Can Reduce Secondary Tumors from Radiation Therapy
On October 27, 2015, Malecare was issued patent 9,168,002 for a device and method for real time simultaneous measurement of radiation at specific parts of your body,. Understanding cumulative radiation exposure in people undergoing ionizing radiation [...]
On The Horizon – Tests That Can Inform Us If A Drug Will Work Before We Take The Drug
We have become very fortunate over the last 6 years because our arsenal of potential drugs to treat advanced, metastatic prostate cancer has grown. All of our new drugs extend life and most offer palliation [...]